Global Health Industry Headlines: IPOs, Drug Breakthroughs, and Policy Shifts | Health

Spanish pharmaceutical giant Grifols is taking its US biopharma division public through an initial public offering while retaining majority ownership. The company will float a minority stake, allowing it to raise capital while keeping strategic control. This move reflects growing trends of healthcare companies restructuring to optimize valuations.